Aprogen Biologics Inc. (KRX:003060)
South Korea flag South Korea · Delayed Price · Currency is KRW
363.00
+4.00 (1.11%)
Last updated: Feb 26, 2026, 11:28 AM KST

Revenue by Segment

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Other Sales
358.95M812.16M---
Other Sales Growth
-55.80%----
Pharmaceutical Business Division
57.57B62.95B64.74B55.74B50.80B
Pharmaceutical Business Division Growth
-8.55%-2.76%16.14%9.74%2.20%
Bio Business Division
9.45B16.87B274.43M--
Bio Business Division Growth
-44.00%6047.42%---
Game Business Division
-357.66M173.22M738.18M2.52B
Game Business Division Growth
-106.48%-76.53%-70.76%110.23%
Insulation Business Division
-6.37B---
Total
67.38B87.36B65.19B56.48B53.32B
Total Growth
-22.88%34.01%15.42%5.93%4.75%
Source: S&P Global Market Intelligence.